|
U.S. Centers for Disease Control and Prevention
• Medical News
Roche Receives U.S. Approval for Hepatitis Drug
February 28, 2005 On Friday, the Swiss pharmaceutical firm Roche Holding said it had received U.S. Food and Drug Administration approval to use its hepatitis C virus drug Pegasys for HCV patients coinfected with HIV. The FDA cleared the treatment, the first hepatitis drug approved for use in HIV patients, to be used in combination with Roche's drug Copegus.
Excerpted from:Back to other news for February 28, 2005 New York Times 02.26.05; Bloomberg News This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
|
